Galectin Therapeutics Inc. (GALT)
Galectin Therapeutics Inc. (GALT) Insider Trading
Directors, officers and holders of more than 10% of GALT report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 268 transactions on file: 1 with code P, 11 with code S and 38 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Uihlein Richard E | Director | M Exercise | 31,825,235 | $3.00 | $95,475,705 |
| Jul 31, 2026 | Uihlein Richard E | Director | M Exercise | 0 | $95475705.00 | Not measured |
| Jul 31, 2026 | Uihlein Richard E | Director | M Exercise | 2,550,932 | $4.05 | $10,331,275 |
| Jul 31, 2026 | Uihlein Richard E | Director | M Exercise | 0 | $10331275.00 | Not measured |
| Jul 14, 2026 | Jamil Khurram | Chief Medical Officer | S Sale | 16,250 | $5.13 | $83,285 |
| Jul 14, 2026 | Jamil Khurram | Chief Medical Officer | M Exercise | 16,250 | Not measured | Not measured |
| Jul 14, 2026 | Jamil Khurram | Chief Medical Officer | M Exercise | 16,250 | $3.04 | $49,400 |
| Jun 29, 2026 | Shlevin Harold H. | Director | M Exercise | 22,268 | Not measured | Not measured |
| Jun 29, 2026 | Shlevin Harold H. | Director | S Sale | 22,268 | $5.04 | $112,231 |
| Jun 29, 2026 | Shlevin Harold H. | Director | M Exercise | 22,268 | $1.23 | $27,390 |
| Jun 29, 2026 | Jamil Khurram | Chief Medical Officer | S Sale | 47,467 | $5.04 | $239,234 |
| Jun 29, 2026 | Jamil Khurram | Chief Medical Officer | M Exercise | 47,467 | $2.50 | $118,668 |
| Jun 29, 2026 | Jamil Khurram | Chief Medical Officer | M Exercise | 47,467 | Not measured | Not measured |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | M Exercise | 2,533 | $2.50 | $6,333 |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | M Exercise | 2,533 | Not measured | Not measured |
| Jun 26, 2026 | Shlevin Harold H. | Director | M Exercise | 7,732 | $1.23 | $9,510 |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | S Sale | 2,533 | $5.00 | $12,665 |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | M Exercise | 2,037 | $2.20 | $4,481 |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | S Sale | 2,037 | $5.00 | $10,185 |
| Jun 26, 2026 | Shlevin Harold H. | Director | S Sale | 7,732 | $5.00 | $38,660 |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | M Exercise | 2,037 | Not measured | Not measured |
| Jun 26, 2026 | Shlevin Harold H. | Director | M Exercise | 7,732 | Not measured | Not measured |
| Jun 23, 2026 | Jamil Khurram | Chief Medical Officer | S Sale | 7,557 | $3.14 | $23,729 |
| Jun 23, 2026 | Jamil Khurram | Chief Medical Officer | M Exercise | 7,557 | Not measured | Not measured |
| Jun 23, 2026 | Jamil Khurram | Chief Medical Officer | M Exercise | 7,557 | $1.23 | $9,295 |
| May 26, 2026 | Jamil Khurram | Chief Medical Officer | M Exercise | 568 | Not measured | Not measured |
| May 26, 2026 | Jamil Khurram | Chief Medical Officer | S Sale | 568 | $3.10 | $1,761 |
| May 26, 2026 | Jamil Khurram | Chief Medical Officer | M Exercise | 568 | $1.23 | $699 |
| Mar 12, 2026 | Brem Henry | Director | A Award | 60,000 | Not measured | Not measured |
| Feb 6, 2026 | ELDRED KARY | Director | P Purchase | 300 | $2.70 | $810 |
| Jan 16, 2026 | Schwartz Elissa J. | Director | A Award | 60,000 | Not measured | Not measured |
| Jan 16, 2026 | AMELIO GILBERT F | Director | A Award | 60,000 | Not measured | Not measured |
| Jan 16, 2026 | LEWIS JOEL | President and CEO | A Award | 120,000 | Not measured | Not measured |
| Jan 16, 2026 | CALLICUTT JACK W | Chief Financial Officer | A Award | 100,000 | Not measured | Not measured |
| Jan 16, 2026 | CALLICUTT JACK W | Chief Financial Officer | A Award | 65,000 | Not measured | Not measured |
| Jan 16, 2026 | OMENN GILBERT S | Director | A Award | 60,000 | Not measured | Not measured |
| Jan 16, 2026 | LEWIS JOEL | President and CEO | A Award | 84,000 | Not measured | Not measured |
| Jan 16, 2026 | LEWIS JOEL | President and CEO | A Award | 91,000 | Not measured | Not measured |
| Jan 16, 2026 | ELDRED KARY | Director | A Award | 60,000 | Not measured | Not measured |
| Jan 16, 2026 | FREEMAN KEVIN D | Director | A Award | 60,000 | Not measured | Not measured |
| Jan 16, 2026 | Shlevin Harold H. | Director | A Award | 60,000 | Not measured | Not measured |
| Jan 16, 2026 | Jamil Khurram | Chief Medical Officer | A Award | 65,000 | Not measured | Not measured |
| Jan 16, 2026 | CARSON BENJAMIN SR | Director | A Award | 60,000 | Not measured | Not measured |
| Jan 16, 2026 | Uihlein Richard E | Director | A Award | 13,158 | $3.04 | $40,000 |
| Jan 16, 2026 | Zordani Richard A. Jr. | Director | A Award | 60,000 | Not measured | Not measured |
| Jan 16, 2026 | Jamil Khurram | Chief Medical Officer | A Award | 100,000 | Not measured | Not measured |
| Jan 16, 2026 | Uihlein Richard E | Director | A Award | 60,000 | Not measured | Not measured |
| Jan 6, 2026 | Jamil Khurram | Chief Medical Officer | S Sale | 21,446 | $3.65 | $78,205 |
| Jan 6, 2026 | LEWIS JOEL | President and CEO | S Sale | 37,698 | $3.58 | $134,853 |
| Jan 6, 2026 | CALLICUTT JACK W | Chief Financial Officer | S Sale | 20,354 | $3.67 | $74,695 |
The full Form 4 history is on the GALT company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.